{"id":"W2005900338","doi":"10.1182/blood-2011-08-371989","title":"Fludarabine and rituximab for relapsed or refractory hairy cell leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"BC Cancer Agency","keywords":"Cladribine; Pentostatin; Fludarabine; Rituximab; Medicine; Purine analogue; Refractory (planetary science); Internal medicine; Hairy cell leukemia; Oncology; Leukemia; Gastroenterology; Chemotherapy; Lymphoma; Purine; Cyclophosphamide; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004389216,0.0001853056,0.0003796384,0.0001006836,0.00009606158,0.00001901467,0.0001019719,0.0001903733,0.0001555197],"category_scores_gemma":[0.0004023707,0.0001387803,0.0000837425,0.0001421367,0.0001181735,0.0001547362,0.00008988565,0.0002401335,0.000116791],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002481084,"about_ca_system_score_gemma":0.003519637,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009419919,"about_ca_topic_score_gemma":0.0000116443,"domain_scores_codex":[0.998426,0.00003432309,0.0002644872,0.0002931487,0.000329419,0.0006525746],"domain_scores_gemma":[0.9986384,0.0003395889,0.00006281644,0.0004604093,0.0000937552,0.0004050481],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.03451584,0.06661489,0.0247755,0.02412095,0.002967943,0.002304069,0.01193437,0.000005889651,0.4276498,0.002505219,0.2916353,0.1109703],"study_design_scores_gemma":[0.5544461,0.002907887,0.004716941,0.0003756283,0.001257636,0.002050171,0.000490242,0.001855883,0.1711644,0.0001177929,0.2598218,0.000795544],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886331,0.004790025,0.00009953466,0.0001712755,0.0001913873,0.0008442379,0.0000192852,0.0001058124,0.005145363],"genre_scores_gemma":[0.9823569,0.0002664519,0.004680583,0.0003030746,0.0008094314,0.0001065293,0.00003679372,0.0000639123,0.01137635],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5199303,"threshold_uncertainty_score":0.6487949,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02851578518528316,"score_gpt":0.3005836549119431,"score_spread":0.27206786972666,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}